Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Oak Ridge Therapeutic Discovery LLC (AKA: ORRxD)
Profile last edited on: 2/29/2024      CAGE:       UEI: XZV5KDH7S3T6

Business Identifier: Preclinical drug discovery
Year Founded
----
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

5100 Poplar Avenue Suite 3122
Memphis, TN 38137
   (901) 683-5350
   N/A
   www.orrxd.com
Location: Single
Congr. District: 08
County: Shelby

Public Profile

ORRxD is a preclinical drug discovery company specializing in: * Virtual high throughput screening for hit discovery; *A pipeline of investigational new drugs; *Chemogenomic database of chemical compounds that bind to targets in the entire human proteome; ORRxD has developed high expertise in structure-based High Performance Computing (HPC)-driven drug screening and assay development in concert with strong medicinal chemistry and biological validation to support a program in hit discovery, lead optimization and preclinical research up to Investigational New Drug (IND) discovery.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$249,658
Phase II Dollars
$0
Total Awarded
$249,658

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 1 NIH $249,658
Project Title: Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.

Key People / Management

  Darryl L Quarles -- Founder & CEO

  Charles J Beech -- Chairman of the Board

  Jeremy C Smith -- Founder & Chief Scientific Officer

Company News

There are no news available.